期刊文献+

他克莫司治疗小儿肾病综合征致急性肾衰竭3例报告 被引量:16

Tacrolimus causes acute renal failure in the treatment of nephrotic syndrome in children: a report of 3 cases
下载PDF
导出
摘要 目的探讨他克莫司治疗肾病综合征导致急性肾衰竭的原因。方法回顾分析2012年1月至2015年12月期间因他克莫司治疗肾病综合征导致急性肾衰竭的3例患儿的临床资料。结果 3例患儿中男2例、女1例,年龄分别为3、11和13岁。临床均符合肾病综合征(原发性、单纯型),1例为频复发、2例为继发激素耐药型,肾脏病理均为微小病变。在激素治疗基础上,加用他克莫司后出现急性肾衰竭,均发生于他克莫司治疗后4周内,且前1周内均有感染诱因,经停用或减量他克莫司并对症、支持治疗,肾功能均于2周内恢复正常,其中2例继续应用他克莫司、1例更换为环孢素A。随访10~42个月,3例患儿的肾功能均维持正常。结论在他克莫司治疗儿童肾病综合征的开始4周内,如果合并感染,可能导致可逆性的急性肾衰竭。 ObjectiveTo explore the causes of acute renal failure resulted from tacrolimus in the treatment of nephrotic syndrome. MethodThe clinical data of acute renal failure caused by tacrolimus in treatment of nephrotic syndrome in 3 children during January 2012 and December 2015 were retrospectively analyzed. ResultsThere were 2 male and 1 female aged 3, 11, and 13 years respectively. Clinical manifestations were consistent with simple type of primary nephrotic syndrome. One child was frequently recurrent and another two were secondary steroid resistant. The renal pathology showed minimal changes. Acute renal failure occurred within 4 weeks after treatment with tacrolimus on the basis of hormone therapy in all patients who had infection within one week. Renal function recovered to normal within 2 weeks after discontinuation or reduction of tacrolimus combined with anti-infection and diuresis treatment. Two children continued with tacrolimus, but the other one was replaced with cyclosporin A. The renal function of all patients remained normal during the follow-up for 10-42 months. ConclusionIn the frst 4 weeks of tacrolimus therapy in children with nephrotic syndrome, infection may lead to reversible acute renal failure.
出处 《临床儿科杂志》 CSCD 北大核心 2017年第6期409-411,共3页 Journal of Clinical Pediatrics
关键词 他克莫司 肾病综合征 急性肾衰竭 tacrolimus nephrotic syndrome acute renal failure
  • 相关文献

参考文献1

二级参考文献14

  • 1Sven B, Jean-Louis, Monique M, et al. A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseases. Kidney Int, 1998,54:536-545.
  • 2Ciro Esposito,Alessia Fomoni, Flavia Cornacchia, et al. Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney Int, 2000,58:123-130.
  • 3Olyei AJ, de Mattos AM, Bennett WM. Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.Drug Saf, 1999, 21:471-476.
  • 4David RD, Iris BM, Javier PP. Histopathology of calcineurin inhibitor-induced nephrotoxicity. Transplantation, 2000, 69 ( 12 suppl) : 11-13.
  • 5Fassi A, Sangalli F, Colombi F. Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporine. Am J Kidney Dis, 1999, 33: 267-275.
  • 6Kurnar KV. Melatonin: an antioxidant protects against cyclosporineinduced nephrotoxicicty. Transplantation, 1999, 67:1065-1068.
  • 7Shihab FS, Andoh TF, Tanner AM, et al. Role of transforming growth factors-b1 in experimental chronic cyclosporine nephropathy.Kidney Int, 1996, 49:1141-1151.
  • 8Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis, 1997, 29:20-26.
  • 9Hutchinson IV. An endothelin-transforming growth factor beta pathway in the nephrotoxicity of immunosuppressive drugs. Curr Opin Nephrol Hypertens, 1998, 7:665-671.
  • 10Kon V, Hunley TE, Fogo A. Combined antagonism of endothelin A/B receptors link endothelin to vasoconstriction whereas angiotensin Ⅱ effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats. Transplantation, 1995, 60:89-95.

共引文献16

同被引文献113

引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部